A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin
NCT05357911
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
AB-106, digoxin
Sponsor
Nuvation Bio Inc.
Collaborators
[object Object]